UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy

被引：0
|
作者：
Qianqian Yu
Tao Zhang
Conghua Xie
Hong Qiu
Bo Liu
Liu Huang
Ping Peng
Jueping Feng
Jigui Chen
Aihua Zang
Xianglin Yuan
机构：
[1] Huazhong University of Science and Technology,Department of Oncology, Tongji Hospital, Tongji Medical College
[2] Huazhong University of Science and Technology,Cancer Center, Union Hospital, Tongji Medical College
[3] Wuhan University,Department of Radiation and Medical Oncology, Zhongnan Hospital
[4] Huazhong University of Science and Technology,Department of Oncology, PuAi Hospital, Tongji Medical College
[5] Wuhan 8th Hospital,Department of Surgery
[6] Hubei Cancer Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 82卷
关键词：
Polymorphism; Irinotecan; Outcome; Metastatic colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 98
页数：11
相关论文
共 50 条
  • [21] Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer
    Hironori Fujii
    Yunami Yamada
    Daichi Watanabe
    Nobuhisa Matsuhashi
    Takao Takahashi
    Kazuhiro Yoshida
    Akio Suzuki
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 123 - 129
  • [22] Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer
    Fujii, Hironori
    Yamada, Yunami
    Watanabe, Daichi
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yoshida, Kazuhiro
    Suzuki, Akio
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (01) : 123 - 129
  • [23] Pharmacogenetic impact of UGT1A1 polymorphisms on pulmonary neuroendocrine tumours treated with metronomic irinotecan-based chemotherapy in Chinese populations
    Ma, Xu
    Han, Sen
    Liu, Ying
    Liu, Jing-Tao
    Fang, Jian
    Zhang, Yan-Hua
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (11) : 1528 - 1535
  • [24] Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin
    Han, Ji-Youn
    Lim, Hyeong-Seok
    Shin, Eun Soon
    Yoo, Yeon-Kyeong
    Park, Yong Hoon
    Lee, Jong-Eun
    Jang, In-Jin
    Lee, Doe Ho
    Lee, Jin Soo
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2237 - 2244
  • [25] Impact of UGT1A1 genotype on overall survival in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens.
    Ichikawa, Wataru
    Uehara, Keisuke
    Minamimura, Keisuke
    Tanaka, Chihiro
    Takii, Yasumasa
    Miyauchi, Hideaki
    Sadahiro, Sotaro
    Shinozaki, Katsunori
    Fukumoto, Kanehisa
    Otsuji, Toshio
    Kambara, Takeshi
    Morita, Satoshi
    Ando, Yuichi
    Arai, Miyuki
    Sugihara, Masahiro
    Sugiyama, Toru
    Ohashi, Yasuo
    Sakata, Yuh
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
    Chalirmporn Atasilp
    Phichai Chansriwong
    Ekaphop Sirachainan
    Thanyanan Reungwetwattana
    Suwannee Sirilerttrakul
    Monpat Chamnanphon
    Apichaya Puangpetch
    Chonlaphat Sukasem
    Scientific Reports, 10
  • [27] Nanoliposomal irinotecan-based chemotherapy after regular irinotecan-based chemotherapy in patients with pancreas cancer.
    Smith, Caleb J.
    Bekaii-Saab, Tanios S.
    Cook, Kathryn
    Eiring, Rachel
    Halfdanarson, Thorvardur Ragnar
    Hanna, Mina Samir Erian
    Jin Zhaohui
    Jochum, Jacob A.
    Ma, Wen Wee
    Mitchell, Jessica L.
    Pitot, Henry C.
    Jatoi, Aminah
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [28] Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
    Atasilp, Chalirmporn
    Chansriwong, Phichai
    Sirachainan, Ekaphop
    Reungwetwattana, Thanyanan
    Sirilerttrakul, Suwannee
    Chamnanphon, Monpat
    Puangpetch, Apichaya
    Sukasem, Chonlaphat
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil
    Yan Wang
    Lin Shen
    Nong Xu
    Jin-Wan Wang
    Shun-Chang Jiao
    Ze-Yuan Liu
    Jian-Ming Xu
    World Journal of Gastroenterology, 2012, 18 (45) : 6635 - 6644
  • [30] UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil
    Wang, Yan
    Shen, Lin
    Xu, Nong
    Wang, Jin-Wan
    Jiao, Shun-Chang
    Liu, Ze-Yuan
    Xu, Jian-Ming
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (45) : 6635 - 6644
12345